share_log

安必平(688393.SH):暂未涉及人体干细胞相关技术

Anbipine (688393.SH): No technology related to human stem cells yet

Gelonghui Finance ·  May 10 03:51

Gelonghui, May 10丨An Biping (688393.SH) said on the interactive platform that the company's main business includes cancer screening and accurate diagnosis, mainly for hospital pathology departments, and has not yet involved human stem cell-related technology.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment